Abstract
There is a surge of public awareness globally about brain disease, often expressed as apprehension, fear, and requests for more information. Much of this heightened concern is based on knowing someone, or some family member, experiencing a brain disease. As a guiding principle, we could agree that every person has a unique brain capacity that should be conserved at the highest level of functional capability to the end of life. Adequate brain function is essential to human health—that is, to physical and mental functioning—over the life span. The promotion of brain health requires an appreciation of the life course contribution to conserving optimal brain function until death. People’s brains age differentially. A majority of older adults, perhaps 60%, retain relatively sound brain function to the end of life. However, 40% of Mexican adults at 80 years of age or older will likely experience some brain functional impairment. These declines in brain health and increases in impairments are not inevitable. Recently researchers in Mexico estimated that up to 56% of Alzheimer’s Disease (AD) can be delayed or avoided altogether with carefully targeted interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Angel, J. L., Vega, W. A., & López-Ortega, M. (2017). Aging in Mexico: Population trends and emerging issues. The Gerontologist, 57(2), 153–162.
Bennet, D. A., Shneider, J. A., Buchman, A. S., et al. (2012). Overview and findings from the rush memory and aging project. Current Alzheimer Research, 9(6), 646–663.
Borenstein, A. R., & Mortimer, J. A. (2016). Alzheimer’s disease: Life course perspectives on risk reduction. London, UK: Elsevier Academic Press.
Brasure, M., Desai, M., Davia, H., et al. (2018). Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia. Annals of Internal Medicine. https://doi.org/10.7326/M17-1528
Butler, M., McCreedy, E., Nelson, V. A., et al. (2018). Does cognitive training prevent cognitive decline? Annals of Internal Medicine. https://doi.org/10.7326/M17-1531
Calderón-Garcidueñas, L., Torres-Jardón, R., Kulesza, R. J., et al. (2020). Alzheimer disease starts in childhood in polluted Metropolitan Mexico City: A major health crisis in progress. Environmental Research. https://doi.org/10.1016/j.envres.2020.109137.
Cruz-Toscano, M., de Santillana-Hernández, S. P., Galindo-Zamitiz, P., Sánchez-Martínez, T., Sánchez-Sandoval, H., Zarate-Martínez, M., & Torres-Arreola, L. (2010). GPC: Diagnóstico y tratamiento de la demencia tipo Alzheimer. Evidencias y recomendaciones. CENETEC. México: Secretaría de Salud. http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/393_IMSS_10_Demencia_Alzheimer/EyR_IMSS_393_10.pdf
Dhana, K., Evans, D. A., Rajan, K. B., Bennet, D. A., & Morris, M. C. (2020). Health lifestyle and the risk of Alzheimer Dementia: Findings from 2 longitudinal studies. Neurology. https://doi.org/10.1212/WNL.0000000000009816
Eid, A., Mhatre, I., & Richardson, J. R. (2019). Gene-environment interactions in Alzheimer’s disease: A potential path to precision medicine. Pharmacology & Therapeutics, 199, 173–187.
Escarce, J. J., Morales, L. S., & Rumbaut, R. G. (2006). The health status and health behaviors of Hispanics. In M. Tienda & Mitchel (Eds.), Hispanics and the future of America (pp. 362–409). Washington, DC: National Research Council (US) Panel on Hispanics in the US/National Academies Press.
Gonzalez, H. M., Tarraf, W., Jian, X., Vásquez, P. M., Kaplan, R., Thyagarajan, B., … Fornage, M. (2018). Apolipoprotein E genotypes among diverse middle-aged and older Latinos: The investigation of neurocognitive aging results. Scientific Reports, 8(1), 1–6.
Greenfield, E. A., & Moorman, S. M. (2019). Childhood socioeconomic status and later life cognition: Evidence from the Wisconsin Longitudinal Study. Journal of Aging and Health, 31(9), 1589–1615. https://doi.org/10.1177/0898264318783489
Gutiérrez-Robledo, L. M., & Arrieta-Cruz, I. (2015). Dementia in Mexico: The need for a National Alzheimer’s plan. Gaceta Médica de México, 151(5), 667–673.
Gutiérrez-Robledo, L. M., Garcia Peña, M. A., Roa Rojas, P. A., & Martinez, A. (2016). Alzheimer’s and other dementias. Mexico City, Mexico: National Geriatrics Institute. http://www.geriatria.salud.gob.mx/contenidos/noticias/diplomado_alzheimer_linea.html
Gutiérrez-Robledo, L. M., Garcia Peña, M. C., López-Ortega, M., Sosa Tinoco, E., & Cabrero Castro, J. E. (2019). Diagnosis and proposal: Long-term care at community level in Mexico. Working paper. Instituto Nacional de Geriatría, Mexico City, Mexico.
Gutiérrez-Robledo, L. M., García Peña, M. C., Roa Rojas, P. A., & Martínez Ruiz, A. (2017). La enfermedad de Alzheimer y otras demencias como problema nacional de salud. Primera edición. Intersistemas. Academia Nacional de Medicina de México, Ciudad de México, México.
Kennedy, G., Hardman, R. J., Macpherson, H., Scholey, A. B., & Pipingas, A. (2017). How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms. Journal of Alzheimer’s Disease, 55(1), 1–18.
Lehtisalo, J., Levälahti, E., Lindström, J., Hänninen, T., Paajanen, T., Peltonen, M., … Tuomilehto, J. (2019). Dietary changes and cognition over 2 years within a multidomain intervention trial—The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER). Alzheimer’s & Dementia, 15(3), 410–417.
Manly, J. J., Schupf, N., Tang, M. X., & Stern, Y. (2005). Cognitive decline and literacy among ethnically diverse elders. Journal of Geriatric Psychiatry and Neurology, 18(4), 213–217.
Medina-Chavez, J., Fuentes-Alexandro, S., & Guzmán-Guzmán, J. (2011). GPC: Diagnosis and treatment of vascular dementia. Evidence and recommendations, CENETEC. Mexico City, Mexico: Ministry of Health. http://www.cenetec.salud.gob.mx/contenidos/gpc/catalogomaestrogpc.html.
Muradás Troitiño, M. C. (2019). Panorama demográfico de México, 2019. In La situación demográfica de México (pp. 15–36). México: Consejo Nacional de Población.
Nation, D. A., Sweeney, M. D., & Montangne, A. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine, 25, 270–276.
National Health and Nutrition Survey Mexico: ENSANUT. (2012). http://ensanut.insp.mx/informes/ENSANUT2012ResultadosNacionales.pdf
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., … Lindström, J. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. The Lancet, 385(9984), 2255–2263.
OECD. (2008). Vivir con la dualidad: Politica fiscal e informalidad en America Latina. Percepciones, no. 81, OECD. https://www.oecd.org/dev/41562757.pdf.
OECD. (2019). Better life index. http://www.oecdbetterlifeindex.org/.
OECD & The World Bank. (2020). Panorama de la Salud: Latinoamérica y el Caribe 2020. Paris, France: OECD Publishing. https://doi.org/10.1787/740f9640-es
Olivari, B. S., French, M. E., & McGuire, L. C. (2020). The public health road map to respond to the growing dementia crisis. Innovation in Aging, 4(1), igz043.
Organización Panamericana de la Salud. (2015). Resolución Cd54.r11, Estrategia y plan de acción sobre demencias en las personas mayores. https://www.paho.org/hq/dmdocuments/2015/CD54-R11-s.pdf
Partida Bush, V. (2005). República Mexicana: Población a mitad de año por sexo y edad, 2005–2050. Proyecciones de la población de México 2005–2050. México, DF: Consejo Nacional de la Población (CONAPO). http://www.conapo.gob.mx/work/models/CONAPO/proyecciones_estatales/Proy05-50.pdf.
Rebok, G. W., Ball, K., Guey, L. T., et al. (2014). Ten-year effects of the advanced cognitive training trial on cognition and everyday functioning in older adults. Journal of the American Geriatrics Society, 62(1), 16–24.
Rodriguez, F. S., Aranda, M., Lloyd, D. A., & Vega, W. A. (2018). Racial and ethnic disparities in dementia risk among individuals with low education. American Journal of Geriartric Psychiatry, 26(9), 966–976.
Russ, T. C. (2018). Intelligence, cognitive reserve, and dementia: Time for intervention? JAMA Network Open, 1(5), e181724.
Shea, R., & Remington, R. (2019). Relative efficacy of a nutritional intervention on cognitive performance across the adults lifespan during early cognitive decline. Journal of Alzheimer’s Disease, 3(1), 251–255.
Shen, L., & Jia, J. (2016). An overview of genome-wide association studies in Alzheirmer’s disease. Neuroscience Bulletin, 32(2), 183–190.
Sprint MIND Investigators. (2019). Effect of intensive vs standard blood pressure control on probable dementia. JAMA, 6, 553–561.
Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. Journal of the International Neuropsychological Society, 8, 448–460.
Tang, M.-X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., … Mayeux, R. (1998). The APOE-e4 allel and the risk of Alzheimer’s Disease among Whites, African Americans, and Hispanics. JAMA, 279, 751–755.
The 10/66 Dementia Research Group. https://www.alz.co.uk/1066/
Tonelli, M., Wiebe, N., Straus, S., Fortin, M., Guthrie, B., James, M. T., … Quan, H. (2017). Multimorbidity, dementia and health care in older people: A population-based cohort study. CMAJ Open, 5(3), E623. https://doi.org/10.9778/cmajo.20170052
Vásquez, P. M., Tarraf, W., Doza, A., Marquine, M. J., Perreira, K. M., Schneiderman, N., … González, H. M. (2019). The cross-sectional association of cognitive stimulation factors and cognitive function among Latino adults in Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 5, 533–541.
WHO. (2019). Risk reduction of cognitive decline and dementia. WHO Guidelines. https://www.who.int/mental_health/neurology/dementia/Dementia_Guidelines_Evidence_Profiles.pdf?ua=1
WHO. Global action plan on the public health response to dementia 2017–2025. http://apps.who.int/iris/bitstream/10665/98377/1/9789275318256_spa.pdf
William, K., & Kemper, S. (2010). Exploring intervention to reduce the decline in ageing. Journal of Psychosocial Nursing and Mental Health Services, 48(5), 42–51.
Wu, S., Rodriguez, F., Haomiao, J., & Vega, W. A. (2019). Latino and Alzheimer’s: Social determinants and personal factors contributing to disease risk. In W. A. Vega, J. A. Angel, L. M. Gutiérrez-Robledo, & K. S. Markides (Eds.), Challenges of Latino aging in the Americas (pp. 63–84). New York, NY: Springer Science.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Vega, W.A., Gutiérrez Robledo, L.M. (2021). Can Brain Health Interventions Reduce Mexico’s Dementia Burden? An Essay. In: Angel, J.L., López Ortega, M., Gutierrez Robledo, L.M. (eds) Understanding the Context of Cognitive Aging. Springer, Cham. https://doi.org/10.1007/978-3-030-70119-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-70119-2_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-70118-5
Online ISBN: 978-3-030-70119-2
eBook Packages: Social SciencesSocial Sciences (R0)